Institutional investors purchased a net $3.9 million shares of AZN during the quarter ended March 2015 and now own 7.14% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPITAL RESEARCH & MANAGEMENT CO... Bought 2.1 Million shares of AstraZeneca
WELLINGTON MANAGEMENT CO. LLP Bought 1.8 Million shares of AstraZeneca
EPOCH INVESTMENT PARTNERS, INC. Bought 1.1 Million shares of AstraZeneca